Developmental effects: oestrogen-induced vaginal changes and organotin-induced adipogenesis

T Iguchi1, H Watanabe, Y Ohta

  • 1Okazaki Institute for Integrative Bioscience, National Institute for Basic Biology, National Institutes of Natural Sciences, Faculty of Life Science, Graduate University for Advanced Studies, Okazaki, Japan. taisen@nibb.ac.jp

Insights

Environmental endocrine disruptors like diethylstilbestrol and tributyltin chloride can permanently alter developmental programming, leading to adverse health effects from fetal development through adulthood in both animals and humans.

Area of Science:

  • Endocrinology
  • Developmental Biology
  • Environmental Health

Background:

  • The fetal origin of adult disease paradigm highlights how early-life exposures impact long-term health.
  • Prenatal exposure to endocrine-disrupting compounds (EDCs) like diethylstilbestrol (DES) causes reproductive abnormalities (DES syndrome).
  • Environmental contaminants like tributyltin chloride (TBT) are known to disrupt development.

Purpose of the Study:

  • To investigate the effects of developmental exposure to endocrine disruptors on health.
  • To explore the mechanisms by which estrogenic compounds and TBT alter developmental programming.
  • To establish TBT as an EDC with effects across species.

Main Methods:

  • Examined persistent proliferation of vaginal epithelial cells in mice neonatally exposed to estrogens.
  • Investigated molecular mechanisms including receptor phosphorylation and growth factor expression.
  • Assessed TBT's effects on adipocyte differentiation in vitro and adipose mass in vivo in vertebrates.
  • Determined TBT's ligand affinity for retinoid X receptor (RXR) and peroxisome proliferator-activated receptor gamma (PPARγ).
  • Analyzed lipid accumulation in various tissues following in utero TBT exposure in mice and ectopic adipocyte formation in Xenopus laevis.

Main Results:

  • Developmental estrogen exposure induces persistent vaginal epithelial cell proliferation via molecular signaling pathways.
  • TBT promotes adipogenesis by activating RXRα and PPARγ, leading to increased adipose mass and lipid accumulation in multiple organs.
  • TBT exposure in utero results in elevated lipid accumulation in adipose depots, liver, and testes of neonate mice.
  • Ectopic adipocytes form in gonadal tissues of Xenopus laevis after organotin exposure.
  • TBT demonstrates adverse effects across species from gastropods to mammals.

Conclusions:

  • Prenatal and early postnatal exposures to endocrine-disrupting compounds permanently alter developmental programming.
  • Estrogenic compounds and TBT serve as strong examples of EDCs with lasting impacts on health.
  • TBT is the first identified environmental EDC to cause adverse effects from invertebrates to mammals, highlighting its broad biological activity and potential human health risks.

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...